Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sunic System Revises Disclosed Contract Value to KRW 8.78 Billion, Excluding Unpaid Balance

Sunic System Revises Disclosed Contract Value to KRW 8.78 Billion, Excluding Unpaid Balance

BitgetBitget2026/10/15 07:43
  • Sunic System on Oct. 2, 2026, reduced its disclosed Merck Performance Materials contract value to KRW 8.78 billion from KRW 9.75 billion.
  • The revision excludes an unpaid KRW 975 million balance under stricter disclosure standards.
  • The contractual total remains KRW 9.75 billion; the scope of OLED research deposition equipment supply is unchanged.
  • The disclosed value represents 14.06% of 2023 consolidated revenue, down from 15.62% previously.
  • A further disclosure will follow receipt of the remaining balance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunic System Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261015900525), on October 15, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

No scientific evidence but viral on social media: “Bodybuilding miracle drug” peptide products deregulation file sent to the White House for review, Hims&Hers (HIMS.US) surged 6% in one day.

The temporary admission policy for peptides has been submitted to the White House for review, and compounding pharmacies are expected to receive approval to produce BPC-157 and other substances; HIMS closed up 6% on Thursday.

智通财经•2026/10/16 00:11